1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd.

1,389.40
INR
-1.40
(-0.10%)
17.74EPS
76.07P/E
139.18BMarket Cap
Nov 05Next Earn
Vijaya Diagnostic Centre Ltd.
NSE:VIJAYA
(National Stock Exchange of India)

Recent

price

1,389.40

P/E

ratio

76.07

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
28.7
33.21
36.92
45.32
44.98
53.57
66.27
79.11
82.07
Revenue per Share
4.5
6.13
8.28
10.76
8.29
11.62
13.99
16.81
17.78
Basic EPS, GAAP
2.89
5.74
9.56
3.5
3.9
9.33
12.55
8.54
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
1
1
1
2
- -
Dividend per Share
20.1
26.92
35.21
45.92
53.37
64.21
77.53
93.02
- -
Book Value per Share
19.35
26.26
34.5
45.26
52.57
50.5
63.78
79.37
- -
Tangible Book Value per Share
102
102
102
102
102
102
103
103
103
Basic Weighted Avg Shares
2,925
3,387
3,765
4,621
4,590
5,476
6,810
8,139
8,436
Sales/Revenue/Turnover
23.43
24.68
30.84
32.68
26.24
29.93
29.75
30.12
30.7
Operating Margin (%)
396
492
505
527
617
570
706
918
947
Depreciation Expense
459
625
845
1,097
846
1,188
1,438
1,730
1,828
Net Income, GAAP
29.16
25.08
24.08
24.91
24.93
24.61
25.56
25.66
25.58
Effective Tax Rate (%)
15.69
18.47
22.44
23.73
18.44
21.7
21.12
21.25
21.67
Profit Margin (%)
803
1,277
1,948
2,038
2,095
1,385
1,446
1,980
- -
Working Capital
1,350
1,417
1,297
1,703
2,330
2,391
2,964
4,000
- -
LT Debt
2,070
2,741
3,592
4,695
5,466
6,599
7,991
9,572
- -
Total Equity
- -
16.41
18.76
19.74
12.48
14.41
14.72
14.74
- -
Return on Invested Capital (%)
- -
18.35
20.11
20.83
13.63
15.71
15.84
15.71
- -
Return on Capital (%)
- -
26.08
26.67
26.52
16.71
19.77
19.79
19.74
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
226
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
4,000
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
103
103
103
Market Capitalization
108,991
88,635
139,178

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
3,219
- -
Cash, Cash Equivalents & STI
- -
2,877
- -
Accounts Receivable, Net
- -
209
- -
Inventories
- -
49
- -
Total Current Liabilities
- -
1,239
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
226
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
21.74%
19.77%
Free Cash Flow
- -
18.25%
-31.84%
Net Income, GAAP
- -
17.74%
20.3%
Sales/Revenue/Turnover
- -
17.05%
19.52%
Total Cash Common Dividend
- -
- -
100.18%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1,562
1,829
1,690
1,732
6,810
2026
1,881
- -
2,052
2,194
8,139
2027
2,310
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
3.06
4.09
3.43
3.39
13.99
2026
3.76
- -
4.2
4.66
16.81
2027
5.16
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
2
2027
- -
- -
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Mobile-health Network Solutions (NASDAQ:MNDR)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Vijaya Diagnostic Centre Limited, headquartered in Hyderabad, India, and founded in 1981, operates as one of India's leading diagnostic chains, providing comprehensive pathology and radiology services across a network of over 160 centres in 25 cities spanning six states including Telangana, Andhra Pradesh, Karnataka, Maharashtra, West Bengal, and the National Capital Region; core offerings encompass clinical pathology, microbiology, haematology, serology, biochemistry, molecular diagnostics, and specialized radiology modalities such as CT scans, MRI-3T, ultrasound, X-ray, PET-CT, and diagnostic cardiology, alongside over 220 basic tests, 740 routine tests, 870 specialized tests, 320 advanced radiology tests, customized health and wellness packages for diverse age groups and lifestyles, home sample collection, and corporate wellness programs. The company maintains NABL-accredited laboratories, ISO 9001:2015 certification for its flagship centre, and NABH-aligned operations, supported by more than 3,000 professionals including 300+ specialized radiologists and pathologists serving over 100 million customers. Recent developments include NCLT approval for the merger with subsidiary Medinova Diagnostic Services Limited effective April 1, 2024, alongside the completion of acquiring the remaining 37.86% stake in Medinova; expansion through commissioning nine hubs in 9MFY25 with plans for nine more hubs and six spokes, including new facilities in Bengaluru with PET-CT and 3T MRI/CT, a hub in Kasba, Kolkata, and upcoming hubs in West Bengal's Krishna Nagar and Barasat; and strong Q2 FY26 financial performance with 10.4% revenue growth to Rs 2.02 billion driven by volume increases in radiology and pathology.